课题基金 / 基金详情

项目摘要

项目成果

Zhaozhu Qiu的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 氯离子是动物细胞中最丰富的游离阴离子。氯离子通道发挥着广泛的功能 包括细胞体积调节、液体分泌、兴奋性调节和细胞内 细胞器他们的生理作用是令人印象深刻的说明了许多遗传疾病涉及氯 调节异常,如囊性纤维化、肌强直和癫痫。然而,尽管最近取得了进展, 在离子通道的贵族家庭中,离子通道长期以来一直是贫穷的表亲。几十年来,该领域 主要由钠钾钙通道控制事实上,仍然有许多电生理学 没有分子身份的良好表征的氯离子通道。这一差距使得无法阐明他们的 以及它们的功能障碍如何导致疾病。在上一个R35 MIRA ESI资助期间,我们 进行了无偏的RNAi筛选,并鉴定了PAC,一种没有序列相似性的新型膜蛋白 其他离子通道,如长期寻求酸或质子激活氯(PAC)通道。通过介导 由于氯离子流入和随后的细胞肿胀,PAC电流与酸诱导的细胞损伤有关。我们 产生PAC敲除小鼠,并证明PAC在体外酸诱导的细胞死亡中起关键作用 和体内缺血性脑损伤。因此,PAC是治疗中风和其他酸中毒相关疾病的潜在药物靶点。 疾病通过结合诱变,膜片钳记录和冷冻电镜,我们首次揭示了 三聚体组装,离子传导途径,阴离子选择性的基础,pH依赖性构象变化, 以及该通道的pH敏感机制。新通道的发现是一个突破, 开辟了一个新的领域。未来5年,我们将重点关注PAC渠道的多样化监管机制 以及我们最近发现的它在囊泡酸化中令人惊讶的生理功能。长期 这个MIRA计划的目标是应用多学科的方法,包括高通量功能 基因组学、膜片钳电生理学、结构生物学、成像和小鼠遗传学尚未充分研究 氯离子通道生物学领域。
英文摘要
PROJECT SUMMARY/ABSTRACT Chloride is the most abundant free anion in animal cells. Chloride channels play a wide range of functions including cell volume regulation, fluid secretion, regulation of excitability, and acidification of intracellular organelles. Their physiological role is impressively illustrated by many genetic diseases involving chloride dysregulation, such as cystic fibrosis, myotonia, and epilepsy. However, despite recent progress, chloride channels have long suffered as poor cousins in the aristocratic family of ion channels. For decades, the field has been dominated by sodium, potassium and calcium channels. Indeed, there are still many electrophysiologically well-characterized chloride channels without molecular identity. This gap makes it impossible to elucidate their precise function and how their dysfunction leads to disease. In the previous R35 MIRA ESI funding period, we performed an unbiased RNAi screen and identified PAC, a novel membrane protein with no sequence similarity to other ion channels, as the long sought-after acid or proton-activated chloride (PAC) channel. By mediating chloride influx and subsequent cell swelling, PAC currents have been implicated in acid-induced cell injury. We generated PAC knockout mice and demonstrated that PAC plays a key role in acid-induced cell death in vitro and ischemic brain injury in vivo. Thus, PAC is a potential drug target for stroke and other acidosis-associated diseases. By combining mutagenesis, patch-clamp recording, and cryo-EM, we revealed for the first time the trimeric assembly, ion conducting pathway, the basis of anion selectivity, pH-dependent conformational change, and pH-sensing mechanism of this new channel. Discovery of a novel channel represents a breakthrough that opens up a new field. In the next 5 years, we will focus on the diverse regulatory mechanisms of the PAC channel and its surprising physiological function in vesicular acidification that we have recently discovered. The long-term goal of this MIRA program is to apply a multi-disciplinary approach including high-throughput functional genomics, patch-clamp electrophysiology, structural biology, imaging, and mouse genetics to the underexplored area of chloride channel biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell Swelling-Activated Chloride Channel in Ischemic Stroke
  • 批准号:
    10034096
  • 项目类别:
  • 资助金额:
    $44.3万
  • 财政年份:
    2020
  • 负责人:
    Zhaozhu Qiu
  • 依托单位:
Cell Swelling-Activated Chloride Channel in Ischemic Stroke
  • 批准号:
    10388400
  • 项目类别:
  • 资助金额:
    $44.3万
  • 财政年份:
    2020
  • 负责人:
    Zhaozhu Qiu
  • 依托单位:
Cell Swelling-Activated Chloride Channel in Ischemic Stroke
  • 批准号:
    10609492
  • 项目类别:
  • 资助金额:
    $44.3万
  • 财政年份:
    2020
  • 负责人:
    Zhaozhu Qiu
  • 依托单位:
Cell Swelling-Activated Chloride Channel in Ischemic Stroke
  • 批准号:
    10208988
  • 项目类别:
  • 资助金额:
    $44.3万
  • 财政年份:
    2020
  • 负责人:
    Zhaozhu Qiu
  • 依托单位:
国内基金
海外基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
  • 批准号:
    22007039
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    王黎明
  • 依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
  • 批准号:
    21172061
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2011
  • 负责人:
    许新华
  • 依托单位: